Showing 1,381 - 1,400 results of 2,530 for search '"vaccines"', query time: 0.09s Refine Results
  1. 1381
  2. 1382

    Life Science 2.0: reframing the life science sector for ‘the benefit on mankind’ by Michaela Vallin, Göran Tomson, Beate Kampmann, Eivind Engebretsen, Stefan Swartling Peterson, Rhoda K. Wanyenze, Ole Petter Ottersen

    Published 2024-12-01
    “…The COVID-19 pandemic put the life science sector to the test. Vaccines were developed at unprecedented speed, benefiting from decades of fundamental research and now honoured by a Nobel Prize. …”
    Get full text
    Article
  3. 1383

    The Beneficial Effect of IL-12 and IL-18 Transduced Dendritic Cells Stimulated with Tumor Antigens on Generation of an Antitumor Response in a Mouse Colon Carcinoma Model by Jagoda Mierzejewska, Katarzyna Węgierek-Ciura, Joanna Rossowska, Agnieszka Szczygieł, Natalia Anger-Góra, Bożena Szermer-Olearnik, Magdalena Geneja, Elżbieta Pajtasz-Piasecka

    Published 2022-01-01
    “…Application of the developed DC-based vaccines may exert a favorable impact on stimulation of an antitumor immune response, especially if these DC vaccines are administered repeatedly.…”
    Get full text
    Article
  4. 1384

    Efficacy of Primate Humoral Passive Transfer in a Murine Model of Pneumonic Plague Is Mouse Strain-Dependent by V. A. Graham, G. J. Hatch, K. R. Bewley, K. Steeds, A. Lansley, S. R. Bate, S. G. P. Funnell

    Published 2014-01-01
    “…This allows licensure of drugs and vaccines using protection data generated in animal models. …”
    Get full text
    Article
  5. 1385

    Médecines créoles guyanaise et haïtienne face au Covid-19 by Marc-Alexandre Tareau, Guillaume Odonne

    Published 2023-12-01
    “…Contrary to the usual pluralism, a strong cleavage between biomedicine and local herbal medicine was noted, and in particular a significant distrust of vaccines by the Creole population. This opposition has largely materialized in the form of a communitarianism of « them » against « us », « their vaccine » against « our plants ». …”
    Get full text
    Article
  6. 1386
  7. 1387

    Chemical and Immunological Characteristics of Aluminum-Based, Oil-Water Emulsion, and Bacterial-Origin Adjuvants by Susana Martiñón, Angel Cisneros, Sergio Villicaña, Ricardo Hernández-Miramontes, Edgar Mixcoha, Psyché Calderón-Vargas

    Published 2019-01-01
    “…Adjuvants are a diverse family of substances whose main objective is to increase the strength, quality, and duration of the immune response caused by vaccines. The most commonly used adjuvants are aluminum-based, oil-water emulsion, and bacterial-origin adjuvants. …”
    Get full text
    Article
  8. 1388

    A New Experimental Infection Model in Ferrets Based on Aerosolised Mycobacterium bovis by Lyanne McCallan, David Corbett, Peter L. Andersen, Claus Aagaard, David McMurray, Claire Barry, Suzan Thompson, Samuel Strain, Jim McNair

    Published 2011-01-01
    “…There is significant interest in developing vaccines to control bovine tuberculosis, especially in wildlife species where this disease continues to persist in reservoir species such as the European Badger (Meles meles). …”
    Get full text
    Article
  9. 1389

    Bovine Genital Campylobacteriosis by Max B. Irsik, Jan K. Shearer

    Published 2007-04-01
    “…Shearer, DVM, MS, describes this venereal disease of cattle formerly known as vibriosis, clinical findings and epidemiology, how to determine if there is a campylobacter problem in a herd, and the use of vaccines. Published by the UF Department of Veterinary Medicine -- Large Animal Clinical Sciences, March 2007. …”
    Get full text
    Article
  10. 1390
  11. 1391
  12. 1392
  13. 1393

    Q Fever: Current State of Knowledge and Perspectives of Research of a Neglected Zoonosis by Sarah Rebecca Porter, Guy Czaplicki, Jacques Mainil, Raphaël Guattéo, Claude Saegerman

    Published 2011-01-01
    “…However, inactive whole-cell vaccines present several defects. Recombinant vaccines have been developed in experimental conditions and have great potential for the future. …”
    Get full text
    Article
  14. 1394

    Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies. by Peter R McIlroy, Le Thanh Mai Pham, Thomas Sheffield, Maxwell A Stefan, Christine E Thatcher, James Jaryenneh, Jennifer L Schwedler, Anupama Sinha, Christopher A Sumner, Iris K A Jones, Stephen Won, Ryan C Bruneau, Dina R Weilhammer, Zhuoming Liu, Sean Whelan, Oscar A Negrete, Kenneth L Sale, Brooke Harmon

    Published 2025-01-01
    “…Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to persist, demonstrating the risks posed by emerging infectious diseases to national security, public health, and the economy. Development of new vaccines and antibodies for emerging viral threats requires substantial resources and time, and traditional development platforms for vaccines and antibodies are often too slow to combat continuously evolving immunological escape variants, reducing their efficacy over time. …”
    Get full text
    Article
  15. 1395

    Attitudes of Final-Year Medical Students in Jordan Towards Volunteering During a Pandemic by Alassaf A, Gharaibeh L, Alkubaisi F, Alkhawaldeh M, Dababseh S, Odeh R

    Published 2025-01-01
    “…Around 60% of students were willing to participate in future voluntary work that does not involve patients infected with COVID-19, while 29.3% of them were willing to do so depending on the type of pandemic and the availability of vaccines. There were 86.1% of students who thought that participating in voluntary work involving infected patients during pandemics, should be optional; where 10.1% suggested that it should be compulsory if vaccines were available.Conclusion: The majority of medical students did not volunteer during the COVID 19 pandemic. …”
    Get full text
    Article
  16. 1396

    Immunological Responses and Epitope Mapping by Tuberculosis-Associated Antigens within the RD1 Region in Japanese Patients by Hideaki Nagai, Maho Suzukawa, Yumi Sakakibara, Ken Ohta, Pedro A. Reche, Koichi Suzuki, Yoshihiko Hoshino

    Published 2014-01-01
    “…Tuberculosis remains a major global health problem worldwide, and hence there is a need for novel vaccines that better induce cellular-mediated immunity (CMI). …”
    Get full text
    Article
  17. 1397
  18. 1398
  19. 1399

    Recent advances of nanovaccines on cancer theranostics by Xiaobing Yuan, Xiaobing Yuan, Xiaobing Yuan, Tianyou Xu, Mubashir Hussain, Bin Liu, Jianwei Zhu, Jianwei Zhu

    Published 2025-02-01
    “…This paper reviewed the research progress of some nanovaccines in cancer immunotherapy, including polymer nanoparticle vaccine, liposome nanoparticle vaccine, cell-based nanoparticle vaccine, inorganic nanoparticle vaccine, adjuvant and auxiliary work. …”
    Get full text
    Article
  20. 1400

    Impact of non-pharmacological interventions on the first wave of COVID-19 in Portugal 2020 by Dinis B. Loyens, Constantino Caetano, Carlos Matias-Dias

    Published 2025-02-01
    “…Introduction: The COVID-19 pandemic caused over 7 million global deaths. Without vaccines during the first wave, governments implemented nonpharmacological interventions (NPIs) such as lockdowns, school closures, and travel restrictions. …”
    Get full text
    Article